Literature DB >> 9376643

Blunted phase-shift responses to morning bright light in premenstrual dysphoric disorder.

B L Parry1, C Udell, J A Elliott, S L Berga, M R Klauber, N Mostofi, B LeVeau, J C Gillin.   

Abstract

Patients with premenstrual dysphoric disorder (PMDD) respond therapeutically to sleep deprivation and light therapy. They have blunted circadian rhythms of melatonin. The authors sought to test the hypothesis that these disturbances are a reflection of a disturbance in the underlying circadian pacemaker or, alternatively, that they reflect a disturbance in the input pathways to the clock. To test these hypotheses, after a 2-month diagnostic evaluation, 8 patients who met DSM-IV criteria for PMDD and 5 normal control (NC) subjects underwent two studies to determine whether PMDD subjects showed (1) altered melatonin sensitivity to light suppression (Study 1) and (2) altered phase-shift responses to morning light as a measure of the functional capacity of the underlying pacemaker (Study 2). In both studies, measurements were made during asymptomatic follicular and symptomatic luteal menstrual cycle phases in PMDD patients. The results of Study 1 showed no significant effect of group or menstrual cycle phase on the amount or percentage of suppression of melatonin by light. The results of Study 2 showed that with respect to the variable of offset time, PMDD subjects, when symptomatic, showed a reduced and directionally altered melatonin phase-shift response to a morning bright light stimulus; in 4 of 5 NC subjects, melatonin offset was advanced by bright morning light, whereas in PMDD subjects, it was delayed (3 subjects) or not shifted (5 subjects) (group effect, p = .045). Study 2 also revealed that area under the curve also changed differentially in PMDD versus NC subjects. In summary, the primary findings from this pilot study suggest that in PMDD there is a maladaptive (directionally altered and blunted) response to light in the symptomatic luteal phase. Because the suppressive effects of light were similar in PMDD and NC subjects, the previously observed low melatonin levels in this disorder do not likely represent a disturbance in pineal reactivity to suprachiasmatic nucleus efferents. Instead, the findings support a possible disturbance in PMDD in the clock itself or its coupling mechanisms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9376643     DOI: 10.1177/074873049701200506

Source DB:  PubMed          Journal:  J Biol Rhythms        ISSN: 0748-7304            Impact factor:   3.182


  10 in total

1.  A phase response curve to single bright light pulses in human subjects.

Authors:  Sat Bir S Khalsa; Megan E Jewett; Christian Cajochen; Charles A Czeisler
Journal:  J Physiol       Date:  2003-04-25       Impact factor: 5.182

2.  Pilot study of the efficacy and safety of a modified-release magnesium 250 mg tablet (Sincromag) for the treatment of premenstrual syndrome.

Authors:  S Quaranta; M A Buscaglia; M G Meroni; E Colombo; S Cella
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

3.  Associations between psychiatric disorders and menstrual cycle characteristics.

Authors:  Mary Lee Barron; Louise H Flick; Cynthia A Cook; Sharon M Homan; Claudia Campbell
Journal:  Arch Psychiatr Nurs       Date:  2008-10       Impact factor: 2.218

4.  Reduced phase-advance of plasma melatonin after bright morning light in the luteal, but not follicular, menstrual cycle phase in premenstrual dysphoric disorder: an extended study.

Authors:  Barbara L Parry; Charles J Meliska; Diane L Sorenson; L Fernando Martínez; Ana M López; Jeffrey A Elliott; Richard L Hauger
Journal:  Chronobiol Int       Date:  2011-05       Impact factor: 2.877

Review 5.  The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications.

Authors:  B L Parry
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

6.  Relationship of morningness-eveningness questionnaire score to melatonin and sleep timing, body mass index and atypical depressive symptoms in peri- and post-menopausal women.

Authors:  Charles John Meliska; Luis Fernando Martínez; Ana María López; Diane Lynn Sorenson; Sara Nowakowski; Barbara Lockhart Parry
Journal:  Psychiatry Res       Date:  2011-01-14       Impact factor: 3.222

7.  Increased sensitivity to light-induced melatonin suppression in premenstrual dysphoric disorder.

Authors:  Barbara L Parry; Charles J Meliska; Diane L Sorenson; Ana Lopez; Luis Fernando Martínez; Richard L Hauger; Jeffrey A Elliott
Journal:  Chronobiol Int       Date:  2010-08       Impact factor: 2.877

8.  Weak evidence of bright light effects on human LH and FSH.

Authors:  Daniel F Kripke; Jeffrey A Elliott; Shawn D Youngstedt; Barbara L Parry; Richard L Hauger; Katharine M Rex
Journal:  J Circadian Rhythms       Date:  2010-05-11

9.  Pilot investigation of the circadian plasma melatonin rhythm across the menstrual cycle in a small group of women with premenstrual dysphoric disorder.

Authors:  Ari Shechter; Paul Lespérance; N M K Ng Ying Kin; Diane B Boivin
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

10.  Effects of exogenous melatonin on sleep and circadian rhythms in women with premenstrual dysphoric disorder.

Authors:  Christophe Moderie; Philippe Boudreau; Ari Shechter; Paul Lespérance; Diane B Boivin
Journal:  Sleep       Date:  2021-12-10       Impact factor: 6.313

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.